Enterprise Value
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary
- ACOR enterprise value is not available.
Performance
ACOR Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
ACOR Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| 6 m6 months | - | - | - |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
ACOR Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | ||||
| 6 m | 6-month | ||||
| 1 y | 1-year | $204 M | $176 M | ||
| 3 y | 3-year | $204 M | $149 M | ||
| 5 y | 5-year | $284 M | $149 M | ||
| alltime | all time | $2.07 B | $31 M |
Acorda Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2023 | $180.17 M(+16.9%) |
| 2022 | $154.12 M(-12.9%) |
| 2021 | $176.96 M(-22.3%) |
| 2020 | $227.79 M(-20.0%) |
| 2019 | $284.84 M(-63.9%) |
| 2018 | $789.06 M(-22.9%) |
| 2017 | $1.02 B(-0.7%) |
| 2016 | $1.03 B(-47.9%) |
| 2015 | $1.98 B(+8.7%) |
| Date | Value |
|---|---|
| 2014 | $1.82 B(+58.2%) |
| 2013 | $1.15 B(+20.7%) |
| 2012 | $952.74 M(+7.5%) |
| 2011 | $885.90 M(-14.0%) |
| 2010 | $1.03 B(+12.4%) |
| 2009 | $916.32 M(+22.0%) |
| 2008 | $751.18 M(+21.6%) |
| 2007 | $617.52 M(+69.5%) |
| 2006 | $364.29 M |
FAQ
- What is the all time high enterprise value for Acorda Therapeutics?
What is the all time high enterprise value for Acorda Therapeutics?
Acorda Therapeutics all-time high enterprise value is $2.07 B